Marshall Wace North America’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-161,715
Closed -$12.5M 1494
2021
Q2
$12.5M Buy
161,715
+157,947
+4,192% +$12.2M 0.05% 338
2021
Q1
$264K Buy
+3,768
New +$285K ﹤0.01% 1347
2019
Q2
Sell
-70,939
Closed -$3.84M 1247
2019
Q1
$3.84M Buy
+70,939
New +$3.99M 0.03% 368
2018
Q3
Sell
-61,237
Closed -$4.05M 1019
2018
Q2
$4.05M Sell
61,237
-250,558
-80% -$16.9M 0.02% 573
2018
Q1
$20.8M Sell
311,795
-403,020
-56% -$27.1M 0.1% 229
2017
Q4
$46.8M Buy
714,815
+193,509
+37% +$12.6M 0.26% 88
2017
Q3
$33.4M Buy
521,306
+388,902
+294% +$25.1M 0.21% 123
2017
Q2
$8.47M Buy
132,404
+88,702
+203% +$5.6M 0.06% 360
2017
Q1
$2.67M Buy
+43,702
New +$2.63M 0.02% 521

Other funds holding DOX

Marshall Wace North America's DOX Position: Q3 2021 in Review

Marshall Wace North America sold out of Amdocs (DOX) in Q3 2021, closing a stake of 161,715 shares — an estimated $12.5M sold.

Marshall Wace North America first reported a position in DOX in Q1 2017 and held it in 9 quarters. The position peaked at $46.8M in Q4 2017. 412 funds tracked by Wall St. Rank hold DOX as of Q3 2021.

  • Marshall Wace North America reported no remaining Amdocs position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 161,715 Amdocs shares in Q3 2021, an estimated $12.5M.
  • Marshall Wace North America first reported a position in Amdocs in Q1 2017 and held it in 9 quarters.
  • Marshall Wace North America's Amdocs position peaked at $46.8M in Q4 2017.
  • 412 funds tracked by Wall St. Rank held Amdocs as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.